Skip to main content
Log in

Regional variation in prescribing for chronic conditions among an elderly population using a pharmacy claims database

  • Original Paper
  • Published:
Irish Journal of Medical Science Aims and scope Submit manuscript

Abstract

Background

Age, gender and geographical regions are recognised factors in inequalities in prescribing for chronic diseases in the elderly.

Aim

To compare the health board regional distribution of chronic disease among the elderly and to examine variation in quality prescribing across age, gender and regions.

Methods

Population based study of prescribing for chronic disease using a national pharmacy claims database. All individuals aged 70 years and over (n=271,518) were eligible.

Results

Over 60% of the elderly in all regions received cardiovascular related medication. The South Eastern, North Western and Western Health Boards had below average prescribing for many chronic conditions. Logistic regression identified age, gender and regional variations in prescribing of preventative therapies for CVD and diabetes.

Conclusion

There is a high prevalence of prescribing for chronic conditions in the elderly in Ireland, and there is evidence of gender, age and residing health board inequalities in prescribing.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Central statistics office. Population and migration estimates. www cso ie 2005.

  2. EHEMU. Health Expectancy in Ireland. www hs le ac uk/reves/ehemutest 2005.

  3. Lamy PP. Prescribing for thr elderly. In: Lamy PP, editor. The health status of the elderly. Littleton Mass: PSG Publicating CO, 1980. 113–117.

    Google Scholar 

  4. Barat I, Andreasen F, Damsgaard EM. The consumption of drugs by 75-year-old individuals living in their own homes.Eur J Clin Pharmacol 2000; 56(6–7):501–509.

    Article  PubMed  CAS  Google Scholar 

  5. Silwer L, Lundborg CS. Patterns of drug use during a 15 year period: data from a Swedish county, 1988–2002.Pharmacoepidemiol Drug Saf 2005; 14(11):813–820.

    Article  PubMed  Google Scholar 

  6. Bennett KE, Williams D, Feely J. Inequalities in prescribing of secondary preventative therapies for ischaemic heart disease in Ireland.Ir Med J 2002; 95(6):169–172.

    PubMed  CAS  Google Scholar 

  7. Bennett KE, Williams D, Feely J. Under-prescribing of cardiovascular therapies for diabetes in primary care.Eur J Clin Pharmacol 2003; 58(12):835–841.

    PubMed  CAS  Google Scholar 

  8. Dornbrook-Lavender KA, Roth MT, Pieper JA. Secondary Prevention of Coronary Heart Disease in the Elderly.Ann Pharmacother 2003; 37(12):1867–1876.

    Article  PubMed  Google Scholar 

  9. Doyle F, De La HD, McGee H, Shelley E, Conroy R. Gender differences in the presentation and management of acute coronary syndromes: a national sample of 1365 admissions.Eur J Cardiovasc Prev Rehabil 2005; 12(4):376–379.

    Article  PubMed  Google Scholar 

  10. Williams D, Bennett K, Feely J. Evidence for an age and gender bias in the secondary prevention of ischaemic heart disease in primary care.Br J Clin Pharmacol 2003; 55(6):604–608.

    Article  PubMed  Google Scholar 

  11. Garavan R, Winder RMH. Health and Social Services for Older People (HeSSOP). national Council on Ageing and Older People, Dublin 2001; www.ncaop.ie.

  12. Adamson J, Lawlor DA, Ebrahim S. Chronic diseases, locomotor activity limitation and social participation in older women: cross sectional survey of British Women’s Heart and Health Study.Age Ageing 2004; 33(3):293–298.

    Article  PubMed  Google Scholar 

  13. Bjerrum L, Sogaard J, Hallas J, Kragstrup J. Polypharmacy: correlations with sex, age and drug regimen. A prescription database study.Eur J Clin Pharmacol 1998; 54(3):197–202.

    Article  PubMed  CAS  Google Scholar 

  14. Maio V, Yuen E, Rabinowitz C et al. Using pharmacy data to identify those with chronic conditions in Emilia Romagna, Italy.J Health Serv Res Policy 2005; 10(4):232–238.

    Article  PubMed  Google Scholar 

  15. Von Korff M, Wagner EH, Saunders K. A chronic disease score from automated pharmacy data.J Clin Epidemiol 1992;45(2):197–203.

    Article  Google Scholar 

  16. O’Hanlon A, Mc Gee H, Barker M et al. Health and social service for older people II (HeSSOPII). National Council on Ageing and Older People 2005; 91.

  17. WHO. Anatomical therapeutics chemical (ATC) classification index with defined daily doses(DDDs). Geneva 2001.

  18. Comhairle na nospideal. Consultant Staffing Jan 2005. www hse ie/comhairle na nospideal 2005.

  19. National cancer registry Ireland. Cancer in Ireland 1994– 2001. www ncri ie 2005.

  20. de Backer G., Ambrosioni E, Borch-Johnsen K et al. European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of eight societies and by invited experts).Atherosclerosis 2004; 173(2):381–391.

    Article  PubMed  Google Scholar 

  21. American Society of Consultant Pharmacists. Drug Regimen Review Guidelines. www ascp com/public 2003.

  22. HSE. GMS(P) B Financial & Statistical analysis of claims and payments 2004. Raven House, Finglas, Dublin 11; 2004.

    Google Scholar 

  23. Johnson Z, Hayes C, Dack P. The standardized prescribing ratio—a new method for comparing prescribing between GPs, controlling for patient age and sex.Pharmacoepidemiol Drug Saf 1997; 6(5):337–345.

    Article  PubMed  CAS  Google Scholar 

  24. DeWilde S, Carey IM, Bremner SA, Richards N, Hilton SR, Cook DG. Evolution of statin prescribing 1994–2001: a case of agism but not of sexism?Heart 2003; 89(4):417–421.

    Article  PubMed  CAS  Google Scholar 

  25. Shepherd J, Blauw GJ, Murphy MB, et al. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial.Lancet 2002; 360(9346):1623–1630.

    Article  PubMed  CAS  Google Scholar 

  26. Bennett KE, Williams D, Feely J. Inequalities in prescribing of secondary preventative therapies for ischaemic heart disease in Ireland.Ir Med J 2002; 95(6):169–172.

    PubMed  CAS  Google Scholar 

  27. Williams D, Bennett K, Feely J. Evidence for an age and gender bias in the secondary prevention of ischaemic heart disease in primary care.Br J Clin Pharmacol 2003; 55(6):604–608.

    Article  PubMed  Google Scholar 

  28. Percudani M, Barbui C, Fortino I, Petrovich L. Antidepressant drug prescribing among elderly subjects: a population-based study.Int J Geriatr Psychiatry 2005; 20(2):113–118.

    Article  PubMed  Google Scholar 

  29. Roberts E, Norris P. Regional variation in anti-depressant dispensings in New Zealand:1993–1997.N Z Med J 2001; 114(125):27–30.

    PubMed  CAS  Google Scholar 

  30. Usher C, Bennett K, Feely J. Regional variation in the prescribing for diabetes and use of secondary preventative therapies in Ireland.Pharmacoepidemiol Drug Saf 2005; 14(8):537–544.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to C. Naughton.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Naughton, C., Bennett, K. & Feely, J. Regional variation in prescribing for chronic conditions among an elderly population using a pharmacy claims database. Ir J Med Sci 175, 32–39 (2006). https://doi.org/10.1007/BF03169170

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03169170

Keywords

Navigation